The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
Join this session to:
- Review the range of delivery options
- Take a deep dive into innovative approaches to consider: AI-assisted chart review, and industry/advocacy partnerships
Learning Objectives
- Understand the importance of natural history studies in rare diseases and personalized medicine.
- Explore various delivery methods for conducting natural history studies.
- Evaluate innovative approaches, including AI-assisted chart review and industry/advocacy partnerships.
- Identify key considerations for selecting the most effective delivery method based on study goals and patient population.

Moderator: Barbara Arone
Vice President, Medical Affairs, Real World Solutions, IQVIA
Medical Affairs Professional Society
Speaker: Stuart Turner
TA Head, General Medicines – Global RWE & Outcomes Research, GSK
Medical Affairs Professional Society
Speaker: Angela Kennedy
Senior Director, Provider and Patient Associations, IQVIA
Medical Affairs Professional Society